Xeris Biopharma Holdings, Inc. announced preliminary financial results for the fourth quarter and full year ended December 31, 2024, in a press release dated January 10, 2025.
AI Assistant
XERIS BIOPHARMA HOLDINGS INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.